$TMO News

Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?

How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends

Thermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat

The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call

Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600

Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650

Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026

Thermo Fisher Scientific's Strong Q2 Not Enough to 'Meaningfully' Change H2 Outlook, RBC Says

TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves

Thermo Fisher Scientific Inc. Q2 2026 Earnings Call Summary

RBC Capital Maintains Sector Perform on Thermo Fisher Scientific, Raises Price Target to $580

Thermo Fisher raises 2026 outlook after 10% growth in Q2

Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650

Thermo Fisher (TMO) Lands ImmuPharma Kapiglucagon Diabetes Manufacturing Role

Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades

Thermo Fisher Scientific Q2 Earnings Call Highlights

TMO Q2 2026 Earnings Call Transcript

Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...

Why Is Thermo Fisher (TMO) Stock Rocketing Higher Today

Thermo Fisher Points to Improving End-Market Activity